Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic
Lewis Buss, Carlos A. Prete, Claudia M. M. Abrahim, et al.
Science (2021) Vol. 371, Iss. 6526, pp. 288-292
Open Access | Times Cited: 518

Showing 26-50 of 518 citing articles:

SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation
Maaran Michael Rajah, Mathieu Hubert, Elodie Bishop, et al.
The EMBO Journal (2021) Vol. 40, Iss. 24
Open Access | Times Cited: 171
SARS-CoV-2 one year on: evidence for ongoing viral adaptation
Thomas P. Peacock, Rebekah Penrice-Randal, Julian A. Hiscox, et al.
Journal of General Virology (2021) Vol. 102, Iss. 4
Open Access | Times Cited: 166
SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study
Andrew G. Letizia, Yongchao Ge, Sindhu Vangeti, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 7, pp. 712-720
Open Access | Times Cited: 164
Neutralising antibody escape of SARS‐CoV‐2 spike protein: Risk assessment for antibody‐based Covid‐19 therapeutics and vaccines
Daniele Focosi, Fabrizio Maggi
Reviews in Medical Virology (2021) Vol. 31, Iss. 6
Open Access | Times Cited: 161
Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: A test-negative case-control study
Matt D. T. Hitchings, Otávio T. Ranzani, Mario Torres, et al.
The Lancet Regional Health - Americas (2021) Vol. 1, pp. 100025-100025
Open Access | Times Cited: 160
Immunity to SARS‐CoV‐2 induced by infection or vaccination
Xaquín Castro Dopico, Sebastian Ols, Karin Loré, et al.
Journal of Internal Medicine (2021) Vol. 291, Iss. 1, pp. 32-50
Open Access | Times Cited: 145
Reduction in life expectancy in Brazil after COVID-19
Márcia C. Castro, Susie Gurzenda, Cássio M. Turra, et al.
Nature Medicine (2021) Vol. 27, Iss. 9, pp. 1629-1635
Open Access | Times Cited: 132
Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy
Sindhu Ramesh, Manoj Govindarajulu, Rachel S. Parise, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1195-1195
Open Access | Times Cited: 131
Estimating the effect of social inequalities on the mitigation of COVID-19 across communities in Santiago de Chile
Nicolò Gozzi, Michele Tizzoni, Matteo Chinazzi, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 130
Changing composition of SARS-CoV-2 lineages and rise of Delta variant in England
Swapnil Mishra, Sören Mindermann, Mrinank Sharma, et al.
EClinicalMedicine (2021) Vol. 39, pp. 101064-101064
Open Access | Times Cited: 129
Collapse of the public health system and the emergence of new variants during the second wave of the COVID-19 pandemic in Brazil
Severino Jefferson Ribeiro da Silva, Lindomar Pena
One Health (2021) Vol. 13, pp. 100287-100287
Open Access | Times Cited: 126
COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials
Zhipeng Yan, Ming Yang, Ching‐Lung Lai
Pharmaceuticals (2021) Vol. 14, Iss. 5, pp. 406-406
Open Access | Times Cited: 125
Reconciling estimates of global spread and infection fatality rates of COVID‐19: An overview of systematic evaluations
John P. A. Ioannidis
European Journal of Clinical Investigation (2021) Vol. 51, Iss. 5
Open Access | Times Cited: 120
Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study
William Marciel de Souza, Mariene R. Amorim, Renata Sesti‐Costa, et al.
The Lancet Microbe (2021) Vol. 2, Iss. 10, pp. e527-e535
Open Access | Times Cited: 115
Model-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant
Renato Mendes Coutinho, Flávia Maria Darcie Marquitti, Leonardo Souto Ferreira, et al.
Communications Medicine (2021) Vol. 1, Iss. 1
Open Access | Times Cited: 114
COVID-19: Rethinking the Lockdown Groupthink
Ari R. Joffe
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 105
SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations
Frederic Grabowski, Grzegorz Preibisch, Stanisław Giziński, et al.
Viruses (2021) Vol. 13, Iss. 3, pp. 392-392
Open Access | Times Cited: 105
Is the cure really worse than the disease? The health impacts of lockdowns during COVID-19
Gideon Meyerowitz‐Katz, Samir Bhatt, Oliver Ratmann, et al.
BMJ Global Health (2021) Vol. 6, Iss. 8, pp. e006653-e006653
Open Access | Times Cited: 101
Sources, diffusion and prediction in COVID-19 pandemic: lessons learned to face next health emergency
Mario Coccia
AIMS Public Health (2023) Vol. 10, Iss. 1, pp. 145-168
Open Access | Times Cited: 86
Involvement of political and socio-economic factors in the spatial and temporal dynamics of COVID-19 outcomes in Brazil: A population-based study
Diego Ricardo Xavier, Eliane Lima e Silva, Flávio Alves Lara, et al.
The Lancet Regional Health - Americas (2022) Vol. 10, pp. 100221-100221
Open Access | Times Cited: 80
Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals
Oren Milman, Idan Yelin, Noga Aharony, et al.
Nature Medicine (2021) Vol. 27, Iss. 8, pp. 1367-1369
Open Access | Times Cited: 100
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
Delphine Planas, Timothée Bruel, Ludivine Grzelak, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 95
Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study
Raphael Sonabend, Lilith K. Whittles, Natsuko Imai, et al.
The Lancet (2021) Vol. 398, Iss. 10313, pp. 1825-1835
Open Access | Times Cited: 93
Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study
Carlos Álvarez-Antonio, Graciela Meza Sánchez, Carlos Calampa, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 7, pp. e925-e931
Open Access | Times Cited: 87
One Year of Coronavirus Disease 2019 (COVID-19) in Brazil: A Political and Social Overview
Matheus Negri Boschiero, Camila Vantini Capasso Palamim, Manoela Marques Ortega, et al.
Annals of Global Health (2021) Vol. 87, Iss. 1, pp. 44-44
Open Access | Times Cited: 86

Scroll to top